BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33386131)

  • 21. Changes in the Extracellular Matrix Are Associated With the Development of Serous Tubal Intraepithelial Carcinoma Into High-Grade Serous Carcinoma.
    van der Steen SCHA; Bulten J; Van de Vijver KK; van Kuppevelt TH; Massuger LFAG
    Int J Gynecol Cancer; 2017 Jul; 27(6):1072-1081. PubMed ID: 28333845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic study of serous tubal intraepithelial carcinoma with invasive carcinoma: is serous tubal intraepithelial carcinoma a reliable feature for determining the organ of origin?
    Gao FF; Bhargava R; Yang H; Li Z; Zhao C
    Hum Pathol; 2013 Aug; 44(8):1534-43. PubMed ID: 23465279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery.
    Rabban JT; Garg K; Crawford B; Chen LM; Zaloudek CJ
    Am J Surg Pathol; 2014 Jun; 38(6):729-42. PubMed ID: 24820399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expansion of secretory cells in the fallopian tubal epithelium in the early stages of the pathogenesis of ovarian serous carcinomas].
    Asaturova AV; Ezhova LS; Faizullina NM; Adamyan LV; Khabas GN; Sannikova MV
    Arkh Patol; 2017; 79(3):10-18. PubMed ID: 28631711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent isolated retroperitoneal HGSC and STIC defined by somatic mutation analysis: a case report.
    Suda K; Nakaoka H; Hata C; Yahata N; Isobe M; Kameyama H; Wakai T; Motoyama T; Inoue I; Yoshihara K; Enomoto T
    Diagn Pathol; 2019 Feb; 14(1):17. PubMed ID: 30744657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
    Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
    Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical Expression Status of p53, CD44v9, and Ki-67 in a Series of Fallopian Tube Lesions of High-grade Serous Carcinoma.
    Sugimoto S; Uchiyama T; Kawahara N; Ohbayashi C; Kobayashi H
    Int J Gynecol Pathol; 2021 Sep; 40(5):419-426. PubMed ID: 34397764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do deeper sections increase the frequency of detection of serous tubal intraepithelial carcinoma (STIC) in the "sectioning and extensively examining the FIMbriated end" (SEE-FIM) protocol?
    Mahe E; Tang S; Deb P; Sur M; Lytwyn A; Daya D
    Int J Gynecol Pathol; 2013 Jul; 32(4):353-7. PubMed ID: 23722507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does serous tubal intraepithelial carcinoma (STIC) metastasize? The clonal relationship between STIC and subsequent high-grade serous carcinoma in BRCA1/2 mutation carriers several years after risk-reducing salpingo-oophorectomy.
    van den Berg CB; Dasgupta S; Ewing-Graham PC; Bart J; Bulten J; Gaarenstroom KN; de Hullu JA; Mom CH; Mourits MJE; Steenbeek MP; van Marion R; van Beekhuizen HJ
    Gynecol Oncol; 2024 May; 187():113-119. PubMed ID: 38759517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective study of a 16 year cohort of BRCA1 and BRCA2 carriers presenting for RRSO: Prevalence of invasive and in-situ carcinoma, with follow-up.
    Blok F; Dasgupta S; Dinjens WNM; Roes EM; van Beekhuizen HJ; Ewing-Graham PC
    Gynecol Oncol; 2019 May; 153(2):326-334. PubMed ID: 30894273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of Peritoneal Carcinoma in women diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) following Risk-Reducing Salpingo-Oophorectomy (RRSO).
    Stanciu PI; Ind TEJ; Barton DPJ; Butler JB; Vroobel KM; Attygalle AD; Nobbenhuis MAE
    J Ovarian Res; 2019 May; 12(1):50. PubMed ID: 31128592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian Mesonephric-like Adenocarcinoma With Multifocal Microscopic Involvement of the Fimbrial Surface: Potential for Misdiagnosis of Tubal Intraepithelial Metastasis as Serous Tubal Intraepithelial Carcinoma Associated With Ovarian High-grade Serous Carcinoma.
    Kim H; Bae GE; Jung YY; Kim HS
    In Vivo; 2021; 35(6):3613-3622. PubMed ID: 34697203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions.
    Kuhn E; Kurman RJ; Vang R; Sehdev AS; Han G; Soslow R; Wang TL; Shih IeM
    J Pathol; 2012 Feb; 226(3):421-6. PubMed ID: 21990067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consensus based recommendations for the diagnosis of serous tubal intraepithelial carcinoma: an international Delphi study.
    Bogaerts JMA; van Bommel MHD; Hermens RPMG; Steenbeek MP; de Hullu JA; van der Laak JAWM; ; Simons M
    Histopathology; 2023 Jul; 83(1):67-79. PubMed ID: 36939551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): A comprehensive review.
    Patrono MG; Iniesta MD; Malpica A; Lu KH; Fernandez RO; Salvo G; Ramirez PT
    Gynecol Oncol; 2015 Dec; 139(3):568-72. PubMed ID: 26407480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential molecular changes and dynamic oxidative stress in high-grade serous ovarian carcinogenesis.
    Kobayashi H; Ogawa K; Kawahara N; Iwai K; Niiro E; Morioka S; Yamada Y
    Free Radic Res; 2017 Oct; 51(9-10):755-764. PubMed ID: 28931330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serous tubal intraepithelial carcinoma, chronic fallopian tube injury, and serous carcinoma development.
    Malmberg K; Klynning C; Flöter-Rådestad A; Carlson JW
    Virchows Arch; 2016 Jun; 468(6):707-13. PubMed ID: 27003156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708).
    Chung YS; Park SY; Lee JY; Park JY; Lee JW; Kim HS; Suh DS; Kim YH; Lee JM; Kim M; Choi MC; Shim SH; Lee KH; Song T; Hong JH; Lee WM; Lee B; Lee IH
    BMC Cancer; 2019 Apr; 19(1):341. PubMed ID: 30971221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of "incidental" serous tubal intraepithelial carcinoma (STIC) in women without a history of or genetic risk factor for high-grade serous carcinoma: A six-year study.
    Meserve EEK; Mirkovic J; Conner JR; Yang E; Muto MG; Horowitz N; Strickland KC; Howitt BE; Crum CP
    Gynecol Oncol; 2017 Jul; 146(1):69-73. PubMed ID: 28479065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.